Suchergebnisse - "Symons, Julian A"

PubPharm (55)

1

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients

enthalten in: Antiviral research | 2024

von Debing, Y. | Vanrusselt, H. | Degrauwe, L. | +20

2

Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models

enthalten in: International journal of molecular sciences | 2023

von Jekle, A. | Thatikonda, S. | Jaisinghani, R. | +15

3

Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles

enthalten in: Journal of virology | 2023

von Vanrusselt, H. | Kum, D. | Taverniti, V. | +14

4

Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Kum, D. | Vanrusselt, H. | Acosta Sanchez, A. | +14

CommentIn: Hepatology. 2023 Oct 1;78(4):1026-1028. - PMID 37368996

5

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir

enthalten in: mBio | 2023

von Jochmans, D. | Liu, C. | Donckers, K. | +22

6

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection : Safety, efficacy, and pharmacokinetic results

enthalten in: PloS one | 2023

von Oey, A. | McClure, M. | Symons, J. | +13

7

ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibitsin vivoefficacy in a Syrian Hamster model

enthalten in: bioRxiv.org | 2022

von Vandyck, K. | Abdelnabi, R. | Gupta, K. | +21

8

The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitorin vitroand confer resistance to nirmatrelvir

enthalten in: bioRxiv.org | 2022

von Jochmans, D. | Liu, C. | Donckers, K. | +22

9

Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules

enthalten in: Molecular therapy. Nucleic acids | 2022

von Kao, C. | Nie, Y. | Ren, S. | +7

10

Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)

enthalten in: bioRxiv.org | 2021

von Luong, X. | Stevens, S. | Jekle, A. | +14

1
2
3
4
5
6
Nächster »
[6]